University of Alabama Study Finds LRRK2 May Be Key to Combating Parkinson`s Disease

(June 11, 2014) – LRRK2, an enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, could slow — or even prevent — Parkinson’s from developing. Read more..